La Force

Researchers are exploring the experiences, needs, and expectations of family caregivers, including parents and siblings, of aging individuals with polyhandicap who are 35 years or older. Polyhandicap is a chronic condition involving profound intellectual disability and severe motor impairments, which significantly limits autonomy and communication. The study aims to better understand the social and emotional challenges faced by these caregivers as their relatives age, to improve support and assistance for these families. The study uses a mixed-methods approach combining quantitative questionnaires and qualitative interviews. Parents and siblings provide information through standardized self-reported questionnaires and interviews about quality of life, coping, emotional intelligence, and burden. Parents data were previously collected, while siblings data will be newly gathered via phone and mail. The study also integrates findings from multiple university and healthcare teams to analyze the experiences from both parents and siblings together. Participants will complete questionnaires and take part in interviews lasting about 30 to 60 minutes to share their experiences. Researchers will analyze these responses to understand family caregivers perspectives on aging relatives with polyhandicap. This includes comparing quantitative and qualitative data over a two-month period. The study helps identify specific caregiver needs and supports better transitions for families dealing with the aging process. Participation may involve filling booklets and engaging in interviews, with all information collected confidentially.

Researchers are evaluating the performance and safety of a mechanical decongestant seawater spray enriched with essential oils from Laboratoires Gilbert in people aged 12 and older who have acute rhinitis with nasal obstruction. The study focuses on how this spray works over a 7-day period to relieve symptoms associated with infections like rhynopharyngitis and rhinosinusitis, as well as non-infectious allergic rhinitis. Participants will use the seawater spray daily during the 7-day study period. The main measure is the sprays effectiveness after 3 days of use. Additional evaluations include effects immediately after the first use and throughout the study on symptoms such as nasal obstruction, secretion thinning, nasal cavity cleansing, irritation relief, and itching. Researchers will also assess patient satisfaction, quality of life improvements, ease of use, and any side effects or device issues. During the study, participants will complete questionnaires to report their symptom changes and feelings about the spray each day. They will be monitored for adverse events and any device problems. The study lasts for a total of 7 days, with assessments at the beginning, during, and at the end of the treatment period to evaluate overall symptom severity and patient experience.